Search Results for: Roche
Trials & Approvals Genentech
Genentech Unveils Positive Two-Year Data For Spinal Muscular Atrophy Drug
2022-10-13
Trials & Approvals Breast Cancer
Action Date Set for Gilead Sciences’ HR+/HER2- breast cancer sBLA
2022-10-11
Trials & Approvals HER2
Roche’s Newly Approved Companion Diagnostic May Open Treatment Options for HER2-low Patients
2022-10-06
Partnerships Sanofi
Sanofi, miRecule To Develop Muscular Dystrophy Candidate In $400+ Million Partnership
2022-10-05
M&A Alexion Pharmaceuticals
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
Policy Patent Infringement
Novartis Ordered to Pay $177.8 million to Plexxikon for Patent Infringements
2022-10-03
Trials & Approvals Duchenne Muscular Dystrophy-dmd
Sarepta Submits BLA for First-Ever Duchenne Muscular Dystrophy Gene Therapy
2022-10-03
Licensing Novo Nordisk
Novo Nordisk Places $700 Million Bet on Ventus’ NLRP3 Inhibitor Program
2022-09-30
Trials & Approvals Biosimilar
Celltrion’s Avastin Biosimilar Gets FDA Greenlight
2022-09-29
M&A Roche
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
Special Pneumonia
Four Dead as Authorities Confirm Argentina Pneumonia Outbreak Caused by Legionella
2022-09-04
PRNewswire
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
2022-08-31
M&A Novartis
Novartis Split: Sandoz Spin Off Forming A Standalone Company
2022-08-25
Partnerships Oncology
Genentech Bets $650 Million Biobucks on China’s Jemincare’s Prostate Cancer Prospect
2022-08-19
Trials & Approvals Oncology
Sanofi Abandons SERD Candidate After Second Breast Cancer Clinical Trial Blow
2022-08-18
1 2 3 4 5 6 … 20
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top